Imitrex 6 MG/0.5 ML cartridges 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FR0AB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,126
Award facts
- Contract value 100% obligated
- $10,126.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,126.17 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Imitrex 6 mg/0.5 mL cartridges. The order, which is a child of AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), represents a firm fixed price purchase utilizing competitive procurement procedures with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 3, 2025. This delivery order is typical of the company's extensive portfolio of pharmaceutical supply contracts supporting federal military and veteran healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for DLA medical procurement. The company holds the significant $999,999,999.00 SPE2DX indefinite delivery contract through December 2026, which functions as a comprehensive global pharmaceutical support vehicle enabling the supply of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Through this contract vehicle and related delivery orders, AmerisourceBergen supports the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, demonstrating substantial capacity to fulfill ongoing pharmaceutical supply requirements for military and defense-related medical programs.
Quick answers
Who was awarded contract SPE2DR26FR0AB?
SPE2DR26FR0AB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26FR0AB worth?
The government has obligated $10,126 on SPE2DR26FR0AB.
Is contract SPE2DR26FR0AB an order under another contract?
Yes. SPE2DR26FR0AB is a delivery order under SPE2DR25D3006, an indefinite delivery contract.
Was contract SPE2DR26FR0AB competed?
The extent of competition for SPE2DR26FR0AB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award